Gomtsyan Arthur, McDonald Heath A, Schmidt Robert G, Daanen Jerome F, Voight Eric A, Segreti Jason A, Puttfarcken Pamela S, Reilly Regina M, Kort Michael E, Dart Michael J, Kym Philip R
Research & Development; AbbVie Inc. ; Chicago, IL, USA.
Temperature (Austin). 2015 May 22;2(2):297-301. doi: 10.1080/23328940.2015.1046013. eCollection 2015 Apr-Jun.
Transient receptor potential vanilloid 1 (TRPV1) is a multifunctional ion channel playing important roles in a numerous biological processes including the regulation of body temperature. Within distinct and tight chemical space of chromanyl ureas TRPV1 ligands were identified that exhibit distinctive pharmacology and a spectrum of thermoregulatory effects ranging from hypothermia to hyperthermia. The ability to manipulate these effects by subtle structural modifications of chromanyl ureas may serve as a productive approach in TRPV1 drug discovery programs addressing either side effect or desired target profiles of the compounds. Because chromanyl ureas in the TRPV1 context are generally antagonists, we verified observed partial agonist effects of a subset of compounds within that chemotype by comparing the in vitro profile of Compound 3 with known partial agonist 5'-I-RTX.
瞬时受体电位香草酸亚型1(TRPV1)是一种多功能离子通道,在包括体温调节在内的众多生物学过程中发挥着重要作用。在色满脲独特且紧密的化学空间内,已鉴定出TRPV1配体,这些配体表现出独特的药理学特性以及从体温过低到体温过高的一系列体温调节作用。通过对色满脲进行细微的结构修饰来操纵这些效应的能力,可能是TRPV1药物发现计划中的一种有效方法,该计划旨在解决化合物的副作用或所需的靶点特征。由于在TRPV1环境中的色满脲通常是拮抗剂,我们通过将化合物3的体外特征与已知的部分激动剂5'-I-RTX进行比较,验证了该化学类型中一部分化合物观察到的部分激动剂效应。